Komrokji RS - Search Results

1

Finding consistency in classifications of myeloid neoplasms: a perspective on behalf of the International Workshop for Myelodysplastic Syndromes.

Zeidan AM, Bewersdorf JP, Buckstein R, Sekeres MA, Steensma DP, Platzbecker U, Loghavi S, Boultwood J, Bejar R, Bennett JM, Borate U, Brunner AM, Carraway H, Churpek JE, Daver NG, Della Porta M, DeZern AE, Efficace F, Fenaux P, Figueroa ME, Greenberg P, Griffiths EA, Halene S, Hasserjian RP, Hourigan CS, Kim N, Kim TK, Komrokji RS, Kutchroo V, List AF, Little RF, Majeti R, Nazha A, Nimer SD, Odenike O, Padron E, Patnaik MM, Roboz GJ, Sallman DA, Sanz G, Stahl M, Starczynowski DT, Taylor J, Xie Z, Xu M, Savona MR, Wei AH, Abdel-Wahab O, Santini V. Zeidan AM, et al. Among authors: komrokji rs. Leukemia. 2022 Dec;36(12):2939-2946. doi: 10.1038/s41375-022-01724-9. Epub 2022 Oct 20. Leukemia. 2022. PMID: 36266326 No abstract available.

2

Burkitt's leukemia with precursor B-cell immunophenotype and atypical morphology (atypical Burkitt's leukemia/lymphoma): case report and review of literature.

Komrokji R, Lancet J, Felgar R, Wang N, Bennett JM. Komrokji R, et al. Leuk Res. 2003 Jun;27(6):561-6. doi: 10.1016/s0145-2126(02)00271-0. Leuk Res. 2003. PMID: 12648517 Review.

3

The myelodysplastic syndromes: classification and prognosis.

Komrokji R, Bennett JM. Komrokji R, et al. Curr Hematol Rep. 2003 May;2(3):179-85. Curr Hematol Rep. 2003. PMID: 12901338 Review.

4

The clinical implications of the World Health Organization's classification of myelodysplastic syndromes.

Komrokji RS, Bennett JM. Komrokji RS, et al. Curr Hematol Rep. 2005 May;4(3):175-81. Curr Hematol Rep. 2005. PMID: 15865868 Review.

5

The myelodysplastic syndromes: diagnosis, molecular biology and risk assessment.

Bennett JM, Komrokji RS. Bennett JM, et al. Among authors: komrokji rs. Hematology. 2005;10 Suppl 1:258-69. doi: 10.1080/10245330512331390311. Hematology. 2005. PMID: 16188686 Free article. Review.

6

Evolving classifications of the myelodysplastic syndromes.

Komrokji RS, Bennett JM. Komrokji RS, et al. Curr Opin Hematol. 2007 Mar;14(2):98-105. doi: 10.1097/MOH.0b013e328017f633. Curr Opin Hematol. 2007. PMID: 17255786 Review.

7

Outcome of patients with myelodysplastic syndromes in the Veterans Administration population.

Komrokji RS, Matacia-Murphy GM, Al Ali NH, Beg MS, Safa MM, Rollison DE, List AF. Komrokji RS, et al. Leuk Res. 2010 Jan;34(1):59-62. doi: 10.1016/j.leukres.2009.03.022. Epub 2009 Apr 14. Leuk Res. 2010. PMID: 19368972

8

Therapy related CMML: a case report and review of the literature.

Ahmed F, Osman N, Lucas F, Neff G, Smolarek T, Bennett JM, Komrokji RS. Ahmed F, et al. Among authors: komrokji rs. Int J Hematol. 2009 Jun;89(5):699-703. doi: 10.1007/s12185-009-0318-1. Epub 2009 May 9. Int J Hematol. 2009. PMID: 19430863 Review.

9

Lenalidomide for treatment of myelodysplastic syndromes: current status and future directions.

Komrokji RS, List AF. Komrokji RS, et al. Hematol Oncol Clin North Am. 2010 Apr;24(2):377-88. doi: 10.1016/j.hoc.2010.02.013. Hematol Oncol Clin North Am. 2010. PMID: 20359632 Review.

10

Myelodysplastic syndromes classification and risk stratification.

Komrokji RS, Zhang L, Bennett JM. Komrokji RS, et al. Hematol Oncol Clin North Am. 2010 Apr;24(2):443-57. doi: 10.1016/j.hoc.2010.02.004. Hematol Oncol Clin North Am. 2010. PMID: 20359636 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

375 results

Search Page

Filters